Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:11 PM
Ignite Modification Date:
2025-12-24 @ 4:11 PM
NCT ID:
NCT03919266
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 18 years
* Sickle Cell Disease patients with ACS with an antibiotic therapy indication
* Signed and informed consent
* Affiliated with social security
Exclusion Criteria:
Documented extra-pulmonary bacterial infection at the time of inclusion;
* Patients who received antibiotics for more than 24 hours before the diagnosis of ACS (during the primary hospitalization)
* Known severe immunosuppression (AIDS, neutropenia (\<1000 PNN), hematology, solid tumor under chemotherapy, transplanted organ); long-term treatment with hydroxy-carbamide is not considered
* Pregnant or lactating women;
* Person deprived of liberty or under legal protection;
* Participation in another interventional study of type Jardé 1
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03919266
Study Brief:
Protocol Section:
NCT03919266